REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer Asia Manufacturing Pte. Ltd. (Singapore)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pfizer Asia Manufacturing Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pfizer Asia Manufacturing Pte. Ltd. is an enterprise in Singapore, with the main office in Singapore. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on October 18, 2006. In 2025, the company reported a net sales revenue increase of 80.69%. Its total assets grew by 79.64% over the same period. The net profit margin of Pfizer Asia Manufacturing Pte. Ltd. increased by 31.63% in 2025.

Headquarters
2 Shenton Way #18-01 Sgx Centre I Singapore
Singapore; Singapore; Postal Code: 068804

Contact Details: Purchase the Pfizer Asia Manufacturing Pte. Ltd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Pfizer Asia Manufacturing Pte. Ltd. report to view the information.
Incorporation Date:
October 18, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
78.14%
Company Performance
Financial values in the chart are available after Pfizer Asia Manufacturing Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
80.69%▲
Total Operating Revenue
80.69%▲
Net Profit/Loss for the Period
324.45%▲
Total Assets
79.64%▲
Total Equity
181.6%▲
Net Profit Margin
31.63%▲
Return on Equity (ROE)
21.42%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?